by Jennifer Roeder | May 27, 2025
A founding goal of TCF was realized as researchers published “Generation of a Biliary Tract Cancer Cell Line Atlas Identifies Molecular Subtypes and Therapeutic Targets“, in Cancer Discovery, a journal of the American Association for Cancer Research. The paper details... by Hayden Roberts | Mar 7, 2024
The work continues, and we can’t do it without you! by Hayden Roberts | Mar 7, 2024
Uniting leaders in rare cancer and tissue-agnostic drug development to identify opportunities for cross-company collaboration. by Hayden Roberts | Mar 7, 2024
A highly interactive, now-annual meeting that promotes collaboration between clinicians, researchers, industry, patient advocates, patients, and others to address the needs of people living with rare cancers. by Hayden Roberts | Mar 7, 2024
Bringing rare cancer experts together with TCF community members to provide insights and answer questions on a range of rare cancer topics from clinical trial participation to genetic and genomic testing. 